• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations.

作者信息

Lakhe M, Furukawa Y, Yonezawa T, Hirose M, Nagashima Y, Miyashita Y, Chiba S

机构信息

Department of Pharmacology, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Jpn J Pharmacol. 1998 Apr;76(4):435-9. doi: 10.1254/jjp.76.435.

DOI:10.1254/jjp.76.435
PMID:9623723
Abstract

To investigate whether a Ca2+ sensitizer increases sinus rate, we studied the effects of racemic thiadiazinone, EMD 53998 (a Ca2+ sensitizer with phosphodiesterase inhibitory action) and its (+)-enantiomer EMD 57033 (a relatively pure Ca2+ sensitizer) on isolated, blood-perfused spontaneously beating right atria and paced left ventricles of the dogs. EMD 53998 increased sinus rate dose-dependently, but EMD 57033 did not. Both substances increased atrial and ventricular contractile force. Propranolol did not affect the responses to each substance. These results suggest that the Ca2+ sensitizing action induced by EMD 57033 does not affect pacemaker currents directly.

摘要

相似文献

1
Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations.
Jpn J Pharmacol. 1998 Apr;76(4):435-9. doi: 10.1254/jjp.76.435.
2
In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.EMD 57033通过钙致敏产生正性肌力作用的体内证据。
J Cardiovasc Pharmacol. 1997 May;29(5):647-55. doi: 10.1097/00005344-199705000-00013.
3
The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.消旋强心剂EMD 53998的两种作用机制,即钙致敏作用和磷酸二酯酶抑制作用,分别存在于不同的对映体中。
J Cardiovasc Pharmacol. 1993 Jun;21(6):883-92. doi: 10.1097/00005344-199306000-00006.
4
EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.EMD 53998在人体心肌中作为钙敏化剂和磷酸二酯酶III抑制剂发挥作用。
Basic Res Cardiol. 1995 Sep-Oct;90(5):365-71. doi: 10.1007/BF00788497.
5
Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Z Kardiol. 2002 Apr;91(4):312-8. doi: 10.1007/s003920200032.
6
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.特发性扩张型心肌病患者心肌中的钙离子致敏作用。新型纯钙离子致敏剂(+)-(5-甲基-6-苯基)-1,3,5,6-四氢-3,6-亚甲基-1,5-苯并二氮杂卓-2,4-二酮与(+)-5-(1-(3,4-二甲氧基苯甲酰基)-1,2,3,4-四氢喹啉-6-基)-6-甲基-3,6-二氢-2H-1,3,4-噻二嗪-2-酮对脱细胞纤维和离体心室肌条的体外差异作用
Arzneimittelforschung. 1996 Jun;46(6):586-93.
7
Effects of EMD 57033 on contraction and relaxation in isolated rabbit hearts.EMD 57033对离体兔心脏收缩和舒张的影响。
Circulation. 1995 Nov 15;92(10):3094-104. doi: 10.1161/01.cir.92.10.3094.
8
Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.新型二嗪农衍生物可区分豚鼠心肌中肌丝Ca2+致敏作用和磷酸二酯酶III抑制作用。
Circ Res. 1992 Jun;70(6):1081-90. doi: 10.1161/01.res.70.6.1081.
9
The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".新型强心剂EMD 53 998是一种强效“钙敏化剂”。
J Cardiovasc Pharmacol. 1991 Jul;18(1):17-27. doi: 10.1097/00005344-199107000-00004.
10
Functional effects of EMD-57033 in isovolumically beating isolated rabbit hearts.EMD - 57033对离体家兔心脏等容搏动的功能影响。
Am J Physiol. 1996 Jul;271(1 Pt 2):H51-8. doi: 10.1152/ajpheart.1996.271.1.H51.